Uptravi tablets 0.4mg by Nippon Shinyaku contain selexipag, indicated for the treatment of pulmonary arterial hypertension (PAH) (YJ code: 2190037F2027, standard: 0.4 mg 1 tablet).
Uptravi tablets 0.4mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
